Multiple Sclerosis Spasticity: Clinical Trials

1 recruiting. 1 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	1	Recruiting 1

Follow Multiple Sclerosis Spasticity: new trials by email Literature Review of Multiple Sclerosis Spasticity trials Research Report on Multiple Sclerosis Spasticity

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity BMS-986368, Placebo - Multiple Sclerosis Spasticity	Phase 2	Recruiting	Celgene	200	2025-06-05	2026-10-01

Narrower conditions

Multiple Sclerosis (1)  ·  Muscle Spasticity (1)

Broader conditions

Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Demyelinating Autoimmune Diseases, CNS (1)  ·  Demyelinating Diseases (1)  ·  Immune System Diseases (1)  ·  Muscle Hypertonia (1)  ·  Muscular Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Neuromuscular Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Sponsors

Celgene (1)

Countries

Australia (1)  ·  Canada (1)  ·  Czechia (1)  ·  Germany (1)  ·  Poland (1)  ·  Puerto Rico (1)  ·  United States (1)